Viewing Study NCT05104918


Ignite Creation Date: 2025-12-25 @ 4:58 AM
Ignite Modification Date: 2025-12-26 @ 3:58 AM
Study NCT ID: NCT05104918
Status: UNKNOWN
Last Update Posted: 2021-11-18
First Post: 2021-10-26
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Vortioxetine as a Novel Anti-depressant With Improvement in Cognitive Abilities
Sponsor: Scotmann Pharmaceuticals
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2022-02
Start Date Type: ESTIMATED
Primary Completion Date: 2022-04
Primary Completion Date Type: ESTIMATED
Completion Date: 2022-06
Completion Date Type: ESTIMATED
First Submit Date: 2021-10-26
First Submit QC Date: None
Study First Post Date: 2021-11-03
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-11-10
Last Update Post Date: 2021-11-18
Last Update Post Date Type: ACTUAL